Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-23 4:59 pm Purchase | 2020-11-23 | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management LP | 3,270,544 8.140% | 3,270,544 (New Position) | Filing History |
| 2020-11-13 4:01 pm Purchase | 2020-11-03 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management LP | 6,886,355 8.340% | 6,886,355 (New Position) | Filing History |
| 2020-11-12 4:22 pm Purchase | 2020-11-02 | 13G | Galecto, Inc. GLTO | Cormorant Asset Management LP | 91,249 9.280% | 91,249 (New Position) | Filing History |
| 2020-10-30 4:00 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cormorant Asset Management LP | 1,964,268 9.780% | 1,964,268 (New Position) | Filing History |
| 2020-10-16 4:00 pm Purchase | 2020-10-06 | 13G | C4 Therapeutics, Inc. CCCC | Cormorant Asset Management LP | 2,490,068 5.790% | 2,490,068 (New Position) | Filing History |
| 2020-07-20 4:03 pm Purchase | 2020-07-10 | 13G | Otonomy, Inc. OTIC | Cormorant Asset Management LP | 2,500,000 5.200% | 2,500,000 (New Position) | Filing |
| 2020-07-06 4:01 pm Purchase | 2020-06-23 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management LP | 3,379,370 8.760% | 3,379,370 (New Position) | Filing History |
| 2020-06-29 5:22 pm Unchanged | 2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Cormorant Asset Management LP | 1,350,000 5.230% | 0 (Unchanged) | Filing History |
| 2020-06-29 5:22 pm Purchase | 2020-06-17 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Cormorant Asset Management LP | 1,350,000 5.230% | 1,350,000 (New Position) | Filing History |
| 2020-06-26 4:17 pm Purchase | 2020-06-16 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LP | 2,514,545 6.700% | 2,514,545 (New Position) | Filing History |
| 2020-05-04 4:15 pm Purchase | 2020-04-24 | 13G | Omeros Corporation OMER | Cormorant Asset Management LP | 3,100,000 5.500% | 2,200,000 (+244.44%) | Filing History |
| 2020-04-27 4:05 pm Purchase | 2020-04-16 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Cormorant Asset Management LP | 1,144,537 5.760% | 1,144,537 (New Position) | Filing History |